- Darren Tobin | September 19, 2011 1:49 PM | Atlanta, GA
Category:
FDA & Prescription Drugs
Patients who have been taking ACTOS, a popular diabetes drug, have been warned by the FDA that there is an increase in the risk of bladder cancer when the drug is ingested for more than 12 months....
- Darren Tobin | September 14, 2011 10:11 AM | Atlanta, GA
Category:
FDA & Prescription Drugs
The FDA recently issued a warning regarding ACTOS and the risk of developing bladder cancer. There have been recent studies suggesting that patients who take ACTOS longer than 12 months increase the...
- Darren Tobin | August 31, 2011 5:38 PM | Atlanta, GA
Category:
Defective & Dangerous Products
Public Citizen, a consumer advocacy group representing more than 225,000 members and supporters nationwide, has petitioned the U.S. Food and Drug Administration to ban the current use of surgical...
- Darren Tobin | August 09, 2011 10:35 AM | Atlanta, GA
Category:
FDA & Prescription Drugs
Actos (pioglitazaone) has recently been associated with the risk of bladder cancer, according to the FDA. On August 4, 2011, the FDA approved updated drug labels for the pioglitazone-containing...
- Jessica Smagacz | November 25, 2008 9:09 PM | Atlanta, GA
Category:
FDA & Prescription Drugs
FDA released an alert yesterday regarding investigation of new data about a potential risk of serious skin reaction from phenytoin therapy in Asian patients positive for a particular human leukocyte...
- Jessica Smagacz | November 14, 2008 7:44 PM | Atlanta, GA
Category:
FDA & Prescription Drugs
In October of 2007, FDA began reviewing safety data that raised concerns about the potential increased risk for atrial fibrillation in patients who were treated with a bisphosphonate drug. The New...